Across CKD stages 3–5, the majority of physicians chose not to intervene until serum 25D reached <30 ng/mL (70–78%), regardless of persistently elevated or continuously rising PTH which KDIGO recommends treating. The gene discussed is PTH; the disease is chronic kidney disease.